RxDoctor Payments Data

Alexander Blinski

Family Medicine · New York, NYNPI 1376856393

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $124,049 of the $158,983 with a category attached, or 78.0%. AbbVie accounts for 99.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $43,068 and has fallen 52.7% since, to $20,381 in 2025. Among family medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,983in general payments, 2019–2025

Across 359 payments — averaging $442.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$158K
  • Galderma Laboratories, L.p.$658
  • Merz North America, Inc.$656

What the payments were for

  • Consulting fees$24,61315%
  • Speaking & faculty fees$124,04978%
  • Travel & lodging$2,8312%
  • Food & beverage$7,4345%
  • Education$560%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)330$157,668
Galderma Laboratories, L.p.21$658
Merz North America, Inc.8$656

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$158,983 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Other family medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →